3134 results for «259»

Filter By

3134 results

Hotline TAVI 2: outcomes with new and established devices

21 May 2025 – From EuroPCR 2025

Review outcomes of new and established TAVI devices through pooled analyses and multicenter studies. Topics include comparisons of balloon-expandable valves, intra- versus supra-annular self-expanding valves, and insights from the ACURATE IDE and ACURATE prime studies.

Hotline TAVI 2: outcomes with new and established devices

Management of stent-related complications

21 May 2025 – From EuroPCR 2025

This session addresses the management of stent-related complications through a series of dramatic clinical cases. Learn methodical approaches to routine and crisis scenarios including primary PCI complications, failure to stent, and unexpected challenges encountered during interventions, highlighting practical bailout techniques and decision-making frameworks.

Management of stent-related complications

Iatrogenic causes for shock treated with LV support

21 May 2025 – From EuroPCR 2025

Explore the management of iatrogenic causes of cardiogenic shock requiring left ventricular support. This session presents complex cases including shock following Bentall procedures, complications during anesthesia induction in bypass surgery, and strategic approaches to prevent and manage these critical scenarios using LV support devices.

Iatrogenic causes for shock treated with LV support

A journey into the ANOCA and INOCA dilemma

21 May 2025 – From EuroPCR 2025

Explore the complex clinical dilemma of ANOCA and INOCA with focus on angina endotypes, prognostic stratification, metabolic phenotype associations, and microvascular function assessment using indices such as microcirculatory resistance and microvascular resistance reserve.

A journey into the ANOCA and INOCA dilemma

Imaging-based strategies for complication management in STEMI

21 May 2025 – From EuroPCR 2025

Discover imaging-based strategies to manage complications during STEMI interventions. This session discusses diagnostic clues such as spasm, stuck devices, and slow flow, and illustrates complex scenarios including extreme stent challenges and application of CTO techniques to STEMI cases for optimized outcomes.

Imaging-based strategies for complication management in STEMI

Cathlab harmony: building high-performance teams

21 May 2025 – From EuroPCR 2025

Discover strategies to build and maintain high-performance teams in the cathlab environment. This session outlines how to foster a collaborative culture, address toxic behaviors, and effectively train and integrate team members to enhance teamwork and procedural success in cardiovascular interventions.

Cathlab harmony: building high-performance teams

Complication management during mitral TEER procedures

21 May 2025 – From EuroPCR 2025

Explore complex case scenarios of complication management during mitral TEER procedures. This session covers haemodynamic challenges, thrombotic events, device malfunctions, and rare embolisation incidents, providing practical insights into effective bailout techniques and procedural problem-solving.

Complication management during mitral TEER procedures

DES and bioadaptator technologies in contemporary practice

21 May 2025 – From EuroPCR 2025

Delve into contemporary practice with this session on drug-eluting stents (DES) and bioadaptator technologies. Gain insights from international studies on complex PCI outcomes, comparative data from randomized trials, and real-world experiences focusing on high bleeding risk patients and elderly cohorts treated with ultrathin strut and new-generation...

DES and bioadaptator technologies in contemporary practice

TAVI for aortic regurgitation: on-label and off-label use

21 May 2025 – From EuroPCR 2025

This session reviews on-label and off-label applications of transcatheter aortic valve implantation (TAVI) for treating aortic regurgitation. Examine complex cases including TAVI in patients with aortic dissection, cardiogenic shock, and valve-in-valve interventions, highlighting innovative procedural approaches and bailout strategies.

TAVI for aortic regurgitation: on-label and off-label use

Management of non-culprit lesions in patients with ACS and multivessel disease

21 May 2025 – From EuroPCR 2025

This session addresses the optimal management of non-culprit lesions (NCL) in patients with acute coronary syndrome (ACS) and multivessel disease. Learn about angiography, imaging, and FFR-guided strategies, timing considerations for PCI in high-risk NSTEMI patients, and patient selection for early staged PCI post-STEMI through detailed case...

Management of non-culprit lesions in patients with ACS and multivessel disease

CTO, modern challenges and solutions

21 May 2025 – From EuroPCR 2025

Address modern challenges in chronic total occlusion (CTO) interventions with this session focusing on the latest technologies and techniques. Learn key procedural strategies and best practices through detailed case studies, and understand how evolving technology is shaping the future of CTO revascularization.

CTO, modern challenges and solutions

New evidence in the PFO closure

21 May 2025 – From EuroPCR 2025

Gain new insights into patent foramen ovale (PFO) closure with this session exploring age-related outcomes, risk of atrial arrhythmia, and patient selection improvements. Review various imaging approaches for assessing residual shunts and compare guidance techniques including TEE, fluoroscopy, and intracardiac echo from recent clinical registries.

New evidence in the PFO closure

Management of mitral regurgitation patients undergoing TMVI screening

13 Jan 2022

This study's results emphasise the strengths and limitations of transcatheter mitral valve implantation (TMVI) as a novel and promising therapy providing predictable elimination of MR in most patients, by S. Ludwig et al.

Management of mitral regurgitation patients undergoing TMVI screening

SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk

07 Nov 2021

Although TAVI is an accepted alternative to surgery in patients with severe aortic stenosis who are at high surgical risk, less is known about long-term comparative outcomes among patients with aortic stenosis who are at intermediate surgical risk. P. Redaelli & M. Pighi review the SURTAVI trial...

Paola Redaelli

Author

Paola Redaelli
M. Pighi

Author

Michele Pighi
SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk
Didn’t find what you were looking for?